Evidence for psychopharmacological treatment of depression in children and adolescents?;Hvilken evidens er der for medikamentel behandling af depression hos børn og unge?

Ugeskrift for Laeger

Volumn 169, Issue 14-15, 2007, Pages 1289-1294

  Thomsen, Hove ^a   Sørensen, Merete Juul ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ADOLESCENT; CHILD; CLINICAL TRIAL; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; DEPRESSION; EVIDENCE BASED MEDICINE; HUMAN; MAJOR DEPRESSION; RANDOMIZED CONTROLLED TRIAL; REVIEW; TREATMENT OUTCOME;

ADOLESCENT; ANTIDEPRESSIVE AGENTS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ANTIDEPRESSIVE AGENTS, TRICYCLIC; CHILD; COGNITIVE THERAPY; DEPRESSION; DEPRESSIVE DISORDER, MAJOR; EVIDENCE-BASED MEDICINE; HUMANS; RANDOMIZED CONTROLLED TRIALS; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME;

EID: 34247272507     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (24)

1. Ford T, Goodman R, Meltzer H. The British child and adolescent mental health survey 1999: the prevalence of DSM-IV disorders. J Am Acad Child Adolesc Psychiatry 2003;42:1203-11.
2. Sørensen MJ, Thomsen PH. Hvilken evidens er der for behandling af depression hos børn og unge med kognitiv terapi? Ugeskr Læger 2007;169:1294-9.
3. Lægemiddelstyrelsen. www.laegemiddelstyrelsen.dk
4. Sørensen CB, Jepsen EB, Thomsen PH et al. Indications for and use of antidepressants in child and adolescent psychiatry - a cross-sectional survey in Denmark. Eur Child Adolesc Psychiatry 2003.;12:114-21.
5. Søndergaard L, Kvist K, Andersen PK et al. Do antidepressants precipitate youth suicide? Eur Child Adolesc Psychiatry 2006;15:232-40.
6. Hazell P, O'Connell D, Heathcote D et al. Tricyclic drugs for depression in children and adolescents. The Cochrane Database of Systematic Reviews 2002; Issue 2. Art. No.: CD002317. DOI: 10.1002/14651858.CD002317.
7. Gundersen K, Geller B. Antidepressants II: tricyclic agents. I: Martin A, Scahill L, Charney DS et al. Pediatric psychopharmacology. Principles and practice. New York: Oxford University Press, 2003:284-94.
8. Wagner KD. Pharmacotherapy for major depression in children and adolescents. Biol Psychiatry 2005;29:819-26.
9. Whittington CJ, Kendall T, Fonagy P et al. Selective serotonin reuptake inhibitors in childhood depression. Lancet 2004;363:1341-5.
10. Wagner KD, Jonas J, Findling RL et al. A double-blind, randomized, placebocontrolled trial of escitalopram in the treatment of pediatric depression. J Am Acad Child Adolesc Psychiatry 2006;45:280-8.
11. March J, Silva S, Petrycki S et al. Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for adolescents with depression Study (TADS) Team. JAMA 2004;292:807-20.
12. Emslie GJ, Rush AJ, Weinberg WA et al. A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression. Arch Gen Psychiatry 1997;54:1031-7.
13. Simeon JG, Dinicola VF, Ferguson HB et al. Adolescent depression: a placebo-controlled fluoxetine treatment study and follow-up. Prog Neuropsychopharmacol Biol Psychiatry 1990;14:791-5.
14. Emslie GJ, Heiligenstein JH, Wagner KD et al. Fluoxetine for acute treatment of depression in children and adolescents: a placebo-controlled, randomized clinical trial. J Am Acad Child Adolesc Psychiatry 2002;41:1205-15.
15. Keller MB, Ryan ND, Stroeber M et al. Efficacy of paroxetine in the treatment of adolescent major depression: a randomized, controlled trial. J Am Acad Child Adolesc Psychiatry 2001;40:762-72.
16. Emslie GJ, Wagner KD, Kutcher S et al. Paroxetine treatment in children and adolescents with major depressive disorder. J Am Acad Child Adolesc Psychiatry 2006;45:709-19
17. Mandoki MW, Tapia MR, Tapia MA et al. Venlafaxine in the treatment of children and adolescents with major depression. Psychopharmacol Bull 1997;33:149-54.
18. Wagner KD, Robb AS, Findling RL et al. A randomized, placebo-controlled trial of citalopram for the treatment of major depression in children and adolescents. Am J Psychiatry 2004;161:1079-83.
19. Von Knorring AL, Olsson G, Thomsen PH et al. A randomized, double-blind, placebo-controlled study of citalopram in adolescents with major depressive disorder. J Clin Psychopharmacol 2006;26:311-5.
20. Wagner KD, Ambrosini P, Rynn MA et al. Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder. Two randomized controlled trials. JAMA 2003;290:1033-41.
21. Wagner KD, Jonas J, Findling RL et al A double-blind, randomized, placebo-controlled trial of escitalopram in the treatment of pediatric depression. J Am Acad Child Adolesc Psychiatry 2006;45:280-8
22. FDA. Joint Meeting of the Psychopharmacologic Drugs Advisory Committee and Pediatrid Advisory Committee 2004; September 13-14. www.fda.gov/ohrms/ dockets/ac/04/briefing/2004-4065bl.htm/august 2006.
23. FDA Talk Paper. FDA approves prozac for pediatric use to treat depression and OCD, January 3, 2003. www.fda.gov/bbs/topics/ANSWERS/2003/ ANS01187.html /august 2006
24. Depression in children - guideline. www.nice.org.uk/page.aspx?o= cg028guidance/ august 2006.